-
Tytuł:
-
Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry.
-
Autorzy:
-
Ha HI; Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Lee EG; Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Lim J; Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Jung SY; Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.; Cancer Healthcare Research Branch, Research Institute, National Cancer Center, Goyang, Korea.
Chang YJ; Division of Cancer Control and Policy, National Cancer Control Institute, National Cancer Center, Goyang, Korea.; Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.
Won YJ; Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea.; Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.
Lim MC; Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.; Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.; Division of Tumor Immunology, Research Institute, National Cancer Center, Goyang, Korea.
-
Źródło:
-
Cancer research and treatment [Cancer Res Treat] 2021 Apr; Vol. 53 (2), pp. 541-548. Date of Electronic Publication: 2020 Nov 18.
-
Typ publikacji:
-
Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: Seoul, Korea : The Association,
-
MeSH Terms:
-
Breast Neoplasms/*complications
Fallopian Tube Neoplasms/*secondary
Neoplasms, Second Primary/*diagnosis
Ovarian Neoplasms/*secondary
Peritoneal Neoplasms/*secondary
Adult ; Aged ; Aged, 80 and over ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Neoplasms, Second Primary/pathology ; Ovarian Neoplasms/pathology ; Peritoneal Neoplasms/pathology ; Registries ; Republic of Korea ; Survival Rate
-
References:
-
Br J Cancer. 1981 Nov;44(5):628-36. (PMID: 7317267)
Clin Cancer Res. 2004 Apr 1;10(7):2473-81. (PMID: 15073127)
JAMA. 2012 Jan 25;307(4):382-90. (PMID: 22274685)
J Natl Cancer Inst. 2005 Sep 21;97(18):1382-4. (PMID: 16174860)
BMC Cancer. 2018 Aug 8;18(1):800. (PMID: 30089478)
Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):995-9. (PMID: 11535553)
Arch Surg. 2006 Feb;141(2):155-60. (PMID: 16490892)
J Clin Oncol. 2004 May 1;22(9):1638-45. (PMID: 15117986)
J Clin Oncol. 2013 Feb 20;31(6):738-43. (PMID: 23284037)
Cancer Epidemiol. 2011 Apr;35(2):112-9. (PMID: 20674535)
Gynecol Oncol. 2011 May 1;121(2):353-7. (PMID: 21324516)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
Cancer Res Treat. 2020 Apr;52(2):335-350. (PMID: 32178489)
J Gynecol Oncol. 2020 Jul;31(4):e56. (PMID: 32266805)
J Breast Cancer. 2020 Apr 07;23(2):115-128. (PMID: 32395372)
Gynecol Oncol. 2012 Feb;124(2):347-53. (PMID: 22264603)
Int J Cancer. 2006 May 1;118(9):2285-92. (PMID: 16342146)
J Gynecol Oncol. 2019 Jan;30(1):e38. (PMID: 30574686)
Gynecol Oncol. 2005 Jan;96(1):222-6. (PMID: 15589605)
Cancer. 2005 Dec 15;104(12):2807-16. (PMID: 16284991)
J Clin Oncol. 2008 Mar 10;26(8):1239-46. (PMID: 18323547)
-
Grant Information:
-
1910132 Republic of Korea National Cancer Center; 1911274 Republic of Korea National Cancer Center
-
Contributed Indexing:
-
Keywords: Breast neoplasms; Epithelial ovarian cancer; Fallopian tube neoplasms; Ovarian neoplasms; Primary peritoneal; Second primary neoplasms
-
Entry Date(s):
-
Date Created: 20201119 Date Completed: 20211102 Latest Revision: 20220422
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC8053875
-
DOI:
-
10.4143/crt.2020.1001
-
PMID:
-
33211942
-
Purpose: A prior history of breast cancer is a risk factor for the subsequent development of primary peritoneal, epithelial ovarian, and fallopian tubal (POFT) cancers. This study aimed to estimate the incidence of secondary POFT malignancy in breast cancer patients and the clinical outcomes of primary and secondary POFT cancer.
Materials and Methods: We searched the Korea Central Cancer Registry to find patients with primary and secondary POFT cancer who had breast cancer in 1999-2017. The incidence rate and standardized incidence ratio were calculated. Additionally, we compared the overall survival of patients with primary and secondary POFT cancer.
Results: Based on the age-standardized rate, the incidence of second primary POFT cancer after breast cancer was 0.0763 per 100,000 women, which increased in Korea between 1999 and 2017. Among the 30,366 POFT cancer patients, 25,721 were primary POFT cancer only, and 493 had secondary POFT cancer after a breast cancer diagnosis. Second primary POFT cancer patients were older at the time of diagnosis (55 vs. 53, p < 0.001) and had a larger proportion of serous histology (68.4% vs. 51.2%, p < 0.001) than patients with primary POFT. There were no differences between the two groups in tumor stage at diagnosis. The 5-year overall survival rates were 60.2% and 56.3% for primary and secondary POFT cancer, respectively (p=0.216).
Conclusion: The incidence of second primary POFT cancer after breast cancer increased in Korea between 1999 and 2017. Besides, second primary POFT cancer patients were diagnosed at older ages and had more serous histology.
